论文部分内容阅读
C225是一种EGFR为靶点的人鼠嵌合型IgG1单克隆抗体,与放疗和/或化疗联合应用时具有协同作用,可以增加患者的放化疗疗效。目前,C225已用于结直肠癌和头颈部肿瘤的治疗,并取得了非常好的疗效。
C225 is a human-mouse chimeric IgG1 monoclonal antibody targeting EGFR and has a synergistic effect with radiotherapy and / or chemotherapy to increase the chemoradiation response in patients. Currently, C225 has been used in colorectal cancer and head and neck cancer treatment, and achieved very good results.